Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Good News for Valeant Pharmaceuticals Intl Inc.

    | Ryan Vanzo

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) gets some good news on its CEO search.

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Still an Option?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been through considerable controversy over the past few months, raising concerns about whether or…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is a Buy if its Parts Sell

    | Jacob Donnelly

    Until Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) sells some of its business and pays down debt, investors should still avoid it.…

    Read more »

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc.?

    | Kay Ng

    Is Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) a falling knife you should avoid, or should you buy it with the potential…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: This Hedge Fund Manager Says Buy

    | Ryan Vanzo

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is under fire, but hedge fund manager Bill Ackman says buy.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: What Michael Pearson’s Testimony Means for the Company

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares declined by more than 7% after Michael Pearson was subpoenaed by a Senate committee.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: What Exactly Is Going On Here?

    | Benjamin Sinclair

    There was another suspicious press release from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Jim Chanos and the Original Short Thesis

    | Benjamin Sinclair

    Jim Chanos was short Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) before the company ran into problems.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 2 Stories That Have Flown Under the Radar

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is fighting a multi-front war.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 Lessons From Bill Ackman’s Painful Experience

    | Benjamin Sinclair

    Bill Ackman has made mistakes with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) that the rest of us can learn from.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Shares Surged as Much as 17% on Monday

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares soared after the company announced Michael Pearson will be stepping down.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown…

    Read more »